Inclusive Costs of NPI Measures for COVID-19 Pandemic: Three Approaches
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
The paper evaluates total inclusive costs of three public health approaches to address the COVID-19 epidemic in the US based on epidemiological projections in Ferguson et al (2020). We calculate and add costs of lost productivity and costs of mortality measured through the value of statistical life. We find that the aggressive approach which involves strict suppression measures and a drastic reduction of economic activity for three months with extensive testing and case tracking afterwards results in the lowest total costs for the society. The approach of doing no non-pharmaceutical measures results in the lowest total costs if the infection fatality rate falls below 0.15%.
Article activity feed
-
SciScore for 10.1101/2020.03.26.20044552: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
No key resources detected.
Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank…
SciScore for 10.1101/2020.03.26.20044552: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
No key resources detected.
Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
